Back to Search
DONNA MALONEY, PHARMD
PHARMD
Pharmacist
NPI: 1245503465Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
28RI01705700(NJ)
Research & Publications (20)
What is the role for donor natural killer cells after nonmyeloablative conditioning?
PMID 19361750·Biol Blood Marrow Transplant·2009
8-other
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.
PMID 19567591·Clin Cancer Res·2009
7-preclinical
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
PMID 19015394·Blood·2009
3-trial
Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo.
PMID 19064724·Blood·2009
3-trial
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
PMID 19450754·Biol Blood Marrow Transplant·2009
4-observational
Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
PMID 18502830·Blood·2008
7-preclinical
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
PMID 18623377·Cancer·2008
3-trial
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
PMID 18759762·Br J Haematol·2008
4-observational
Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation.
PMID 19041059·Biol Blood Marrow Transplant·2008
8-other
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
PMID 18215785·Biol Blood Marrow Transplant·2008
3-trial
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
PMID 18311781·Cancer·2008
8-other
What is the role of maintenance rituximab in follicular NHL?
PMID 18251281·Oncology (Williston Park)·2008
6-review
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 18794548·J Clin Oncol·2008
8-other
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
PMID 18452065·Leuk Lymphoma·2008
8-other
Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
PMID 18724296·Bone Marrow Transplant·2008
8-other
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
PMID 18940683·Biol Blood Marrow Transplant·2008
4-observational
High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.
PMID 18949614·Leuk Lymphoma·2008
4-observational
Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
PMID 18567989·Clin Adv Hematol Oncol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1691 US HIGHWAY 9
TOMS RIVER, NJ 08755 - Phone
- (732) 914-3826
Quick Facts
- NPI
- 1245503465
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile